SUBSCRIBE

Breaking News on Supplements, Health & Nutrition - EuropeUS edition

Top Headlines

Diabetes game changer? Researchers to look at green tea catechins & insulin

Botanical supplier Plandaí Biotechnology has signed a research agreement with North West University in South Africa to investigate green tea catechins and type 2 diabetes. 

Set to begin in November this year, the trials will take place in Mauritius where rates of type 2 diabetes are among the highest in the world. ©iStock/IPGGutenbergUKLtd

Males with more muscle don’t need more protein, study finds

More protein intake equals more muscle growth, according to a Scottish study, but the amount of growth does not depend on an individual’s overall muscle mass.

AUD$9m project puts algae under the nutritional spotlight in New South Wales

An AUD$9m (US$6.9m) project to boost the potential for algae in the nutrition, supplement and bio-industry has been launched in New South Wales.

EU rejects more than 90% of all health claims: Study

The EU has authorised only a small fraction of the health claims submitted to it, with a number of categories seeing no authorised claims at all, according to a new analysis of the bloc’s uber-strict health claim process.

Infant formula sales slump at Biostime but firm bullish over future growth

Sales at Chinese infant nutrition firm Biostime dropped by 14% in the first half of 2016 to RMB1.46bn (US$220m), with the Biostime brand – which accounts for 86% of the company’s sales – down 5.4% and the value brand Adimil down 65.7%.

Key Industry Events